Invention Grant
- Patent Title: Genetically modified cell and process for use of said cell
-
Application No.: US15687192Application Date: 2017-08-25
-
Publication No.: US10023890B2Publication Date: 2018-07-17
- Inventor: Nick Johannes Petrus Wierckx , Tom Daniel Elink Schuurman , Sipko Maarten Kuijper , Harald Johan Ruijssenaars
- Applicant: Purac Biochem B.V.
- Applicant Address: NL Gorinchem
- Assignee: Purac Biochem B.V.
- Current Assignee: Purac Biochem B.V.
- Current Assignee Address: NL Gorinchem
- Agency: Bozicevic, Field & Francis LLP
- Agent Glenn J. Foulds; Bret E. Field
- Priority: NL2006359 20110308
- Main IPC: C12N9/04
- IPC: C12N9/04 ; C12P17/04 ; C12N9/02 ; C07K14/195
Abstract:
The present invention relates to the field of biotransformation of furanic compounds. More particular the present invention relates to novel genetically modified cells with improved characteristics for biocatalytic transformation of furanic compounds and a vector suitable for the genetic modification of a host cell. Further aspects of the invention are aimed at processes for biotransformation of 5-(hydroxymethyl)furan-2-carboxylic acid (HMF-acid) and its precursors with the use of the cell according to the invention.
Public/Granted literature
- US20180023105A1 Genetically Modified Cell and Process for Use of Said Cell Public/Granted day:2018-01-25
Information query
